Related Experiment Video
Updated: Mar 14, 2026
03:47
Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
Published on: September 27, 2024
1.6K
Advancements and Refinement in Facial Neuromodulators
Reza Kordestani1,2, Kevin H Small1,2, Rod J Rohrich1,2
1Dallas, Texas.
Plastic and Reconstructive Surgery
|September 28, 2016
Summary
Neuromodulators like Botox are increasingly used for facial rejuvenation. This guide details their safe and effective use for treating dynamic facial wrinkles, emphasizing anatomy and technique.
Area of Science:
- Cosmetic Dermatology
- Facial Plastic Surgery
- Neuromodulator Treatments
Background:
- Neuromodulator use for facial rejuvenation surged by 748% (2000-2014).
- Understanding facial anatomy and neurotoxin properties is crucial for optimal outcomes and complication avoidance.
- Key FDA-approved neurotoxins include onabotulinumtoxin A (Botox), abobotulinumtoxin A (Dysport), and incobotulinumtoxin A (Xeomin).
Purpose of the Study:
- To provide a structured approach for treating dynamic facial rhytides with neuromodulators.
- To educate practitioners on indications, facial analysis, and injection techniques.
- To outline post-procedure care and potential complications.
Main Methods:
- Review of current FDA-approved neurotoxins and their characteristics.
- Stepwise approach to facial analysis and treatment planning.
- Detailed injection techniques and post-procedure management protocols.
Main Results:
- Emphasizes that neurotoxin dosages and effects are not interchangeable.
- Highlights the importance of mastering one product before switching.
- Confirms equivalent success rates for all products when used by trained practitioners.
Conclusions:
- Proper training in facial anatomy, analysis, and neurotoxin specifics is essential.
- A systematic approach ensures minimized complications and maximized results in neuromodulator therapy.
- This article serves as a comprehensive guide for practitioners using neuromodulators for facial rejuvenation.
Related Concept Videos
01:31Skeletal Muscle Relaxants: Therapeutic Uses
1.1K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.1K
01:14Muscles for Facial Expressions
5.4K
The craniofacial muscles are a collection of approximately 20 thin skeletal muscles situated beneath the skin of the face and scalp. These muscles, primarily responsible for the vast array of human facial expressions, originate from the bones or fibrous structures of the skull and extend outwards to connect with the skin. While most skeletal muscles in the body are enveloped in thick fascia, facial muscles generally have a more delicate fascial covering, with the buccinator muscle being a...
5.4K
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
1.1K
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
1.1K
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
2.5K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
2.5K